Detection of SARS Coronavirus in Patients with Severe Acute Respiratory Syndrome by Conventional and Real-Time Quantitative Reverse Transcription-PCR Assays
Author(s) -
Leo L. M. Poon,
Kwok Hung Chan,
On Kei Wong,
Timothy Cheung,
Iris H. Y. Ng,
BoJian Zheng,
WH Seto,
KwokYung Yuen,
Yi Guan,
Malik Peiris
Publication year - 2004
Publication title -
clinical chemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.705
H-Index - 218
eISSN - 1530-8561
pISSN - 0009-9147
DOI - 10.1373/clinchem.2003.023663
Subject(s) - reverse transcription polymerase chain reaction , covid-19 , real time polymerase chain reaction , virology , reverse transcriptase , coronavirus , medicine , betacoronavirus , respiratory system , sars virus , severe acute respiratory syndrome , biology , polymerase chain reaction , messenger rna , gene , pathology , infectious disease (medical specialty) , disease , outbreak , genetics
A novel coronavirus (CoV) was recently identified as the agent for severe acute respiratory syndrome (SARS). We compared the abilities of conventional and real-time reverse transcription-PCR (RT-PCR) assays to detect SARS CoV in clinical specimens.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom